Clinical Trial Update: Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating denosumab, teriparatide, or their combination for postmenopausal osteoporosis. The study has completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Teriparatide (Teriparatide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2018-05-08